Showing results (181-190 of 579) with videos related to
Sort By:
Pageof 58
Cell Cycle (Georgetown, Tex.)|September 14, 2006
PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGFRobert Hnasko, John Mark Carter, Freddy Medina, et al.Current Pharmaceutical Design|June 23, 2007
Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular diseasePhilippe G Frank, Ghada S Hassan, Juan A Rodriguez-Feo, et al.Cell Cycle (Georgetown, Tex.)|October 17, 2012
Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistanceAhmed F Salem, Diana Whitaker-Menezes, Anthony Howell, et al.FEBS Letters|June 2, 1998
Caveolin-3 is not an integral component of the dystrophin glycoprotein complexR H Crosbie, H Yamada, D P Venzke, et al.Cell Cycle (Georgetown, Tex.)|January 25, 2007
Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phaseKai Fang, Wei Fu, Andrew R Beardsley, et al.Diabetes|March 1, 2005
Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissueAlex W Cohen, William Schubert, Dawn L Brasaemle, et al.The American Journal of Pathology|January 16, 2010
microRNA, cell cycle, and human breast cancerZuoren Yu, Renato Baserga, Lide Chen, et al.Chest|October 1, 1994
Exertional hypotension in spinal cord injuryM L King, S W Lichtman, J T Pellicone, et al.International Journal of Molecular Sciences|December 15, 2017
G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging ConceptsErnestina M De Francesco, Federica Sotgia, Robert B Clarke, et al.Oncotarget|September 17, 2017
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapyErnestina Marianna De Francesco, Marcello Maggiolini, Herbert B Tanowitz, et al.Pageof 58